Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemophilia Inhibitor Genetics Study (HIGS)

NCT00166387 is registered in ClinicalTrials.gov with Skane University Hospital as lead sponsor.

NCT NCT00166387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00166387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemophilia Inhibitor Genetics Study (HIGS)
Lead sponsor
Skane University Hospital
Phase
Observational
Overall status
Completed
Start date
April 30, 2003
Completion date
December 31, 2013
Enrollment
1,137 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a with inhibitor